CYTOGENIX INC
10SB12G/A, EX-27.1, 2000-07-19
MEDICAL LABORATORIES
Previous: CYTOGENIX INC, 10SB12G/A, EX-11.1, 2000-07-19
Next: CYTOGENIX INC, 10SB12G/A, EX-27.1, 2000-07-19



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM AUDITED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                             DEC-31-1999
<PERIOD-END>                                  DEC-31-1999
<CASH>                                             29,554
<SECURITIES>                                            0
<RECEIVABLES>                                      25,100
<ALLOWANCES>                                            0
<INVENTORY>                                             0
<CURRENT-ASSETS>                                   55,595
<PP&E>                                             61,445
<DEPRECIATION>                                    (19,802)
<TOTAL-ASSETS>                                    107,210
<CURRENT-LIABILITIES>                             563,386
<BONDS>                                                 0
                                   0
                                             0
<COMMON>                                           29,010
<OTHER-SE>                                       (485,186)
<TOTAL-LIABILITY-AND-EQUITY>                      107,210
<SALES>                                                 0
<TOTAL-REVENUES>                                    1,375
<CGS>                                                   0
<TOTAL-COSTS>                                  (1,653,239)
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                      0
<INCOME-PRETAX>                                (1,651,864)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                            (1,651,864)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                      (3,067,007)
<NET-INCOME>                                   (4,718,871)
<EPS-BASIC>                                         (0.01)
<EPS-DILUTED>                                           0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission